Med Spa @SanduskyWellnessPeptide Library

← Learn

Compounds ·

Nootropic Peptides: What the Research Says About Cognitive Enhancement

Semax, Selank, Dihexa, and Cerebrolysin: what the published studies on these brain-focused peptides actually looked at.

From ReVia

The brain is the most complex organ in the known universe, and peptides that influence cognitive function represent some of the most intellectually fascinating areas of modern research. Nootropic peptides — compounds studied for their effects on memory, learning, neuroprotection, and cognitive performance — are drawing increasing attention from neuroscience researchers worldwide.

Semax: Russia's Neuroscience Contribution

Semax, a synthetic analog of ACTH(4-7), was developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. Published research has shown effects on BDNF (brain-derived neurotrophic factor) expression — a protein critical for neuronal survival, growth, and synaptic plasticity.

Studies have also examined Semax's effects on dopaminergic and serotonergic systems, making it a valuable research tool for studying the intersection of neurotrophic signaling and monoamine neurotransmission.

Selank: The Anxiolytic Peptide

Selank, a synthetic analog of the immunomodulatory peptide tuftsin, has been studied extensively for its effects on GABAergic neurotransmission and anxiety-related behaviors in animal models. Published research suggests it modulates the balance between excitatory and inhibitory neurotransmission without the sedation associated with traditional GABAergic compounds.

Dihexa: The Potent Newcomer

Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) has generated significant research interest since its 2013 publication in the Journal of Pharmacology and Experimental Therapeutics. Studies showed it was approximately 10 million times more potent than BDNF in promoting synaptic connectivity, working through the hepatocyte growth factor (HGF) receptor system.

Cerebrolysin: The Neuropeptide Mix

Cerebrolysin is a mixture of low-molecular-weight neuropeptides derived from porcine brain tissue. It has been studied in over 200 published clinical trials and preclinical studies, primarily in the context of neurodegenerative research and cognitive function. Its complex composition — multiple peptides working together — makes it a unique research tool for studying neuroprotection.

The Future of Cognitive Peptide Research

As our understanding of brain plasticity deepens, nootropic peptides will likely play an increasingly important role in neuroscience research. These compounds give researchers precise tools to probe specific aspects of cognitive function, neuroplasticity, and neuroprotection.

Research Use Only (RUO): The information presented in this library summarizes published scientific research and is provided for educational and informational purposes only. It is not intended as medical advice, diagnosis, or treatment recommendations. All compounds referenced carry a Research Use Only designation and are intended for laboratory research use only.